Feedback / Questions
Xtandi (enzalutamide) - Pfizer, Astellas
Yonsa (abiraterone acetate) - Churchill Pharma
Lynparza (olaparib) - Merck (MSD), AstraZeneca
https://www.targetedonc.com/view/parp-inhibitors-excite-prostate-cancer-treatment-paradigm
Jan 3, 2021
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next